Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
TrueBlue Inc (NYSE: TBI) closed the day trading at $7.58 down -1.30% from the previous closing price of $7.68. In other words, the price has decreased by -$1.30 from its previous closing price. On the day, 95598.0 shares were traded. TBI stock price reached its highest trading level at $7.6395 during the session, while it also had its lowest trading level at $7.435.
Ratios:
For a better understanding of TBI, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.85 and its Current Ratio is at 1.85. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.16.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BMO Capital Markets on May 22, 2023, Upgraded its rating to Outperform and sets its target price to $20 from $18 previously.
On May 26, 2022, BMO Capital Markets Downgraded its rating to Market Perform which previously was Outperform and also lowered its target price recommendation from $36 to $20.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TBI now has a Market Capitalization of 224056464 and an Enterprise Value of 272828768. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.13 while its Price-to-Book (P/B) ratio in mrq is 0.68. Its current Enterprise Value per Revenue stands at 0.163 whereas that against EBITDA is 638.943.
Stock Price History:
Over the past 52 weeks, TBI has reached a high of $14.91, while it has fallen to a 52-week low of $6.63. The 50-Day Moving Average of the stock is -3.12%, while the 200-Day Moving Average is calculated to be -17.64%.
Shares Statistics:
Over the past 3-months, TBI traded about 183.92K shares per day on average, while over the past 10 days, TBI traded about 130240 shares per day. A total of 29.50M shares are outstanding, with a floating share count of 28.27M. Insiders hold about 4.36% of the company’s shares, while institutions hold 96.96% stake in the company. Shares short for TBI as of 1734048000 were 1012265 with a Short Ratio of 5.50, compared to 1731628800 on 955853. Therefore, it implies a Short% of Shares Outstanding of 1012265 and a Short% of Float of 5.1.
Earnings Estimates
As of right now, 4.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.18, with high estimates of -$0.01 and low estimates of -$0.28.
Analysts are recommending an EPS of between -$0.54 and -$0.69 for the fiscal current year, implying an average EPS of -$0.6. EPS for the following year is -$0.11, with 4.0 analysts recommending between $0.15 and -$0.34.
Revenue Estimates
3 analysts predict $385.04M in revenue for the current quarter. It ranges from a high estimate of $391.48M to a low estimate of $378.53M. As of the current estimate, TrueBlue Inc’s year-ago sales were $492.17MFor the next quarter, 3 analysts are estimating revenue of $369.25M. There is a high estimate of $388M for the next quarter, whereas the lowest estimate is $356.2M.
A total of 3 analysts have provided revenue estimates for TBI’s current fiscal year. The highest revenue estimate was $1.57B, while the lowest revenue estimate was $1.56B, resulting in an average revenue estimate of $1.57B. In the same quarter a year ago, actual revenue was $1.91BBased on 3 analysts’ estimates, the company’s revenue will be $1.55B in the next fiscal year. The high estimate is $1.59B and the low estimate is $1.51B.
